Irish Health Repository >
Hospital Research >
St. Vincent's University Hospital >
Clusterin and chemotherapy sensitivity under normoxic and graded hypoxic conditions in colorectal cancer.
|Files in This Item:|
There are no files associated with this item.
|Title: ||Clusterin and chemotherapy sensitivity under normoxic and graded hypoxic conditions in colorectal cancer.|
|Affiliation: ||Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland.|
|Citation: ||Clusterin and chemotherapy sensitivity under normoxic and graded hypoxic conditions in colorectal cancer. 2012, 43 (2):305-13 J Gastrointest Cancer|
|Journal: ||Journal of gastrointestinal cancer|
|Issue Date: ||Jun-2012 |
|PubMed ID: ||21487682|
|Abstract: ||In vitro studies have shown that clusterin modulates treatment sensitivity in a number of human cancers; however, the interaction between clusterin expression and hypoxia in controlling treatment response in CRC has not previously been examined. The aim of this study was to assess the effect of clusterin overexpression in CRC cells on sensitivity to 5-fluorouracil (5-FU), oxaliplatin and FOLFOX treatment under normoxic and graded hypoxic conditions.|
|MeSH: ||Antineoplastic Agents|
Cell Line, Tumor
Drug Resistance, Neoplasm
Enzyme-Linked Immunosorbent Assay
|Appears in Collections: ||St. Vincent's University Hospital|
this identifier to cite or link
to this item:
|Related articles on PubMed|
SN-38 overcomes chemoresistance of colorectal cancer cells induced by hypoxia, through HIF1alpha.
Murono K, Tsuno NH, Kawai K, Sasaki K, Hongo K, Kaneko M, Hiyoshi M, Tada N, Nirei T, Sunami E, Takahashi K, Kitayama J
|See all 97 articles|
All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.